Summary: Treatment with disease-modifying therapy is the most effective way to slow MS progression, modify the course of the disease, and maintain optimal brain health. Yet, for many people living with MS, these life-changing treatments remain out of reach. My guests are Tim Coetzee, the Chief Advocacy, Research, & Services Officer, and Bari Talente, the EVP of Advocacy for the National MS Society, and we're talking about the barriers to accessing MS medications and what can be done to bring those barriers down.
